Comparing cancer care in the United States and Europe reveals significant differences in approach . The US system, often characterized as market-driven , tends to emphasize cutting-edge innovations , frequently resulting in greater costs and unequal access to care. Conversely, many European systems operate under universal healthcare models, which f